{"id":"NCT00893113","sponsor":"Chesapeake Urology Research Associates","briefTitle":"An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms","officialTitle":"A Phase 3, Double Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of Alfuzosin in Treating Men With ED and Mild LUTS.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-06","primaryCompletion":"2012-10","completion":"2012-10","firstPosted":"2009-05-05","resultsPosted":"2016-08-01","lastUpdate":"2018-03-09"},"enrollment":74,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Erectile Dysfunction","Lower Urinary Tract Symptoms"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Alfuzosin","otherNames":[]}],"arms":[{"label":"Placebo, Then Alfuzosin","type":"PLACEBO_COMPARATOR"},{"label":"Alfuzosin, Then Placebo","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the effect of Alfuzosin in treating Erectile Dysfunction in men with mild lower urinary tract symptoms based upon a change from baseline in erectile function (EF) domain of International Index of Erectile Function (IIEF).","primaryOutcome":{"measure":"Change From Baseline Erectile Function Domain of the International Index of Erectile Function","timeFrame":"Baseline and 12 Weeks","effectByArm":[{"arm":"Placebo","deltaMin":2.84,"sd":7.492},{"arm":"Alfuzosin","deltaMin":2.84,"sd":8.704}],"pValues":[]},"eligibility":{"minAge":"30 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":8},"locations":{"siteCount":4,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":36},"commonTop":[]}}